U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
175891175891Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health PopulationCompletedNo Results AvailableDiabetes Mellitus|Schizophrenia|Psychotic DisordersProcedure: Screening|Procedure: Managementhttps://ClinicalTrials.gov/show/NCT00253240
175892175892A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer Disease|DementiaDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00253227
175893175893Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release FormulationCompletedNo Results AvailableAlzheimer Disease|DementiaDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00253214
175894175894A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer Disease|DementiaDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00253201
175895175895A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer Disease|DementiaDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00253188
175896175896A Study of the Effectiveness and Safety of Topiramate for the Prevention of MigraineCompletedNo Results AvailableVascular Headaches|MigraineDrug: topiramatehttps://ClinicalTrials.gov/show/NCT00253175
175897175897A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With HaloperidolCompletedNo Results AvailableBipolar Disorders|Manic DisorderDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00253162
175898175898A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar DisorderCompletedNo Results AvailableBipolar Disorders|Manic DisorderDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00253149
175899175899A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCompletedNo Results AvailableSchizophrenia|Psychotic DisordersDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00253136
175900175900A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNo Results AvailableDementia|Alzheimer Disease|Dementia, VascularDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00253123
175901175901A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: risperidone|Drug: haloperidolhttps://ClinicalTrials.gov/show/NCT00253110
175902175902The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort StudyActive, not recruitingNo Results AvailableCerebrovascular Accident|Transient Ischemic Attack|Myocardial InfarctionBehavioral: Interventionhttps://ClinicalTrials.gov/show/NCT00253097
175903175903Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: CD-LD ER|Drug: Carbidopa-Levodopahttps://ClinicalTrials.gov/show/NCT00253084
175904175904Early Integrated Intervention in Severe Affective DisordersCompletedNo Results AvailableDepressive Disorder|Bipolar DisorderBehavioral: Prophylactic combined medical and psychological treatmenthttps://ClinicalTrials.gov/show/NCT00253071
175905175905Study Of Perennial Allergic Rhinitis In PediatricsCompletedNo Results AvailableRhinitis, Allergic, PerennialDrug: Cetirizine Dry Syruphttps://ClinicalTrials.gov/show/NCT00253058
175906175906Motivating HIV+ Women: Risk Reduction and ART AdherenceCompletedNo Results AvailableHIV|AIDSBehavioral: Motivational groupshttps://ClinicalTrials.gov/show/NCT00253045
175907175907Pain Relief Investigation of NeuroModulation Therapy in Adult HumansTerminatedNo Results AvailableChronic Musculoskeletal PainDevice: PRIMAhttps://ClinicalTrials.gov/show/NCT00253032
175908175908A Comparison of Continuation Rates for Three Hormonal Contraceptive MethodsCompletedHas ResultsContraceptionhttps://ClinicalTrials.gov/show/NCT00253019
175909175909Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human UrotheliumTerminatedNo Results AvailableInterstitial Cystitis|Bladder Diseases|Urinary IncontinenceProcedure: Tissue examination for protein- and mRNA-expression of NOhttps://ClinicalTrials.gov/show/NCT00253006
17591017591012 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional VomitingTerminatedNo Results AvailableVomitingDrug: DDP225https://ClinicalTrials.gov/show/NCT00252993
175911175911CANDIS - Targeted Treatment for Cannabis DisordersActive, not recruitingNo Results AvailableCannabis Use DisorderBehavioral: Psychotherapyhttps://ClinicalTrials.gov/show/NCT00252980
175912175912Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)TerminatedHas ResultsAtrial Fibrillation|InflammationDrug: Atorvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00252967
175913175913Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord InjuryCompletedNo Results AvailableInjuries, Spinal Cord|PainDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00252954
175914175914Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaCompletedNo Results AvailableProstate Cancer|Post-Brachytherapy Bladder Outlet ObstructionDevice: Memokath 028SW Urethral Stenthttps://ClinicalTrials.gov/show/NCT00252941
175915175915Health Impact Study of Aquatabs in Tamale, GhanaCompletedNo Results AvailableDiarrheaOther: Sodium dichloroisocyanurate (NaDCC) tablets|Other: Placebohttps://ClinicalTrials.gov/show/NCT00252928
175916175916Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic ShockCompletedNo Results AvailableSepsisBiological: GM-CSF (verum)https://ClinicalTrials.gov/show/NCT00252915
175917175917Emergency Department Initiated Tobacco Treatment (EDITT)CompletedNo Results AvailableTobacco UseBehavioral: Behavior change counselinghttps://ClinicalTrials.gov/show/NCT00252902
175918175918Doxil Topotecan Doublet Cancer StudyCompletedNo Results AvailableSmall Cell Lung Cancer|Pancreatic Cancer|Head and Neck Cancer|Gastric Cancer|Esophageal CancerDrug: Topotecan and pegylated doxorubicinhttps://ClinicalTrials.gov/show/NCT00252889
175919175919GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesTerminatedNo Results AvailableType 2 DiabetesDrug: tesaglitazarhttps://ClinicalTrials.gov/show/NCT00252876
175920175920DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsCompletedNo Results AvailableAsthmaDrug: Symbicort, used twice daily (b.i.d) and as needed (prn)|Drug: Budesonide Turbuhaler 200 µg|Drug: Fluticasone Discus 250 µg|Drug: Formoterol Turbuhaler 4.5 µg|Drug: Terbutaline Turbuhaler 0.5 mg|Drug: Salbutamol pressurized metered dose inhaler (pMDI) 100 µg|Drug: Salmeterol Discus 50 µg|Drug: Budesonide/Formoterol Turbuhaler 160/4.5 µg|Drug: Fluticasone/Salmeterol Discus 250/50 µg|Drug: Fluticasone/Salmeterol Discus 500/50 µg|Drug: Theophylline 200 mg|Drug: Theophylline 300 mg|Drug: Singulair 10 mghttps://ClinicalTrials.gov/show/NCT00252863

* Görseller ve İçerik tekif hakkına sahip olabilir